BAL PHARMA (India) Today

BALPHARMA -  India Stock  

INR 136.90  3.60  2.56%

Market Performance
16 of 100
Odds Of Distress
Less than 32
BAL PHARMA is selling at 136.90 as of the 26th of January 2022; that is -2.56 percent decrease since the beginning of the trading day. The stock's lowest day price was 133.9. BAL PHARMA has about a 32 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. Equity ratings for BAL PHARMA LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of January 2021 and ending today, the 26th of January 2022. Click here to learn more.
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients in India and internationally. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India. BAL PHARMA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on Bombay Stock Exchange.. The company has 14.17 M outstanding shares. More on BAL PHARMA LTD
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

BAL PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. BAL PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BAL PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BAL PHARMA LTD appears to be risky and price may revert if volatility continues
The company reported the revenue of 1.74 B. Net Loss for the year was (94.95 M) with profit before overhead, payroll, taxes, and interest of 839.38 M.
BAL PHARMA LTD has accumulated about 35.07 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Roughly 64.0% of the company shares are held by company insiders
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BAL PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
BAL PHARMA LTD (BALPHARMA) is traded on Bombay Stock Exchange in India . The company currently falls under 'Mid-Cap' category with current market capitalization of 1.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BAL PHARMA's market, we take the total number of its shares issued and multiply it by BAL PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BAL PHARMA LTD operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 14.17 M outstanding shares. BAL PHARMA LTD has accumulated about 35.07 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Check BAL PHARMA Probability Of Bankruptcy
BAL PHARMA LTD retains a total of 14.17 Million outstanding shares. BAL PHARMA LTD shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 63.62 percent of BAL PHARMA LTD outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check BALPHARMA Ownership Details

BALPHARMA Stock Price Odds Analysis

What are BAL PHARMA's target price odds to finish over the current price? In regard to a normal probability distribution, the odds of BAL PHARMA jumping above the current price in 90 days from now is near 1%. The BAL PHARMA LTD probability density function shows the probability of BAL PHARMA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon BAL PHARMA LTD has a beta of -0.1874 suggesting as returns on benchmark increase, returns on holding BAL PHARMA are expected to decrease at a much lower rate. During the bear market, however, BAL PHARMA LTD is likely to outperform the market. Additionally, the company has an alpha of 0.4566, implying that it can generate a 0.46 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 136.9HorizonTargetOdds Up 136.9 
99.72%90 days
Based on a normal probability distribution, the odds of BAL PHARMA to move above the current price in 90 days from now is near 1 (This BAL PHARMA LTD probability density function shows the probability of BALPHARMA Stock to fall within a particular range of prices over 90 days) .

BAL PHARMA LTD Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. BAL PHARMA market risk premium is the additional return an investor will receive from holding BAL PHARMA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BAL PHARMA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BAL PHARMA's alpha and beta are two of the key measurements used to evaluate BAL PHARMA's performance over the market, the standard measures of volatility play an important role as well.

BALPHARMA Stock Against Markets

Picking the right benchmark for BAL PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BAL PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BAL PHARMA is critical whether you are bullish or bearish towards BAL PHARMA LTD at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in BAL PHARMA without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now


Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Continue to Trending Equities. Note that the BAL PHARMA LTD information on this page should be used as a complementary analysis to other BAL PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Tools for BALPHARMA Stock

When running BAL PHARMA LTD price analysis, check to measure BAL PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BAL PHARMA is operating at the current time. Most of BAL PHARMA's value examination focuses on studying past and present price action to predict the probability of BAL PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BAL PHARMA's price. Additionally, you may evaluate how the addition of BAL PHARMA to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Shere Portfolio
Track or share privately all of your investments from the convenience of any device